Clinical Research On Treatment Early Renal Damage In Primary Hypertension With Tianmagoutengyin Drink

Objective:Observation of Effect of Tianmagouteng Decoction on early renal damage in primary hypertension clinical efficacyMethods:Select hypertension in patients with early renal damage in 60 cases.Taken randomly divided into test group and control group,n=30. Oral contrast material to蒙诺(fosinopril),and symptomatic supportive care, the experimental group in the control group on the basis Tianmagouteng drink treatment services.4 weeks for a course of treatment,observed before and after treatment in patients with 24-hour ambulatory blood pressure monitoring(ABPM),a urineβ2-microglobulin(β2-MG),urinary microalbumin(mAlb),blood routine,urine routine,liver function,renal function,such as indicators and records of two major changes in symptoms and make evaluation.Result:Treatment group and control group of antihypertensive efficacy,the overall effect of TCM Syndrome There was a significant difference(P <0.05),the treatment group than the control group.The treatment group not only can significantly lower blood pressure,but also a significant reduction in urinaryβ2-MG and mAlb emission,efficacy was superior to the control group(P<0.05).Conclusion:Tianmagouteng drink early treatment of high blood pressure is an effective drug for renal injury,with blood pressure and improve the results of clinical symptoms,such as the role,and on the early renal damage in hypertension with renal protection.